DrugPatentWatch Database Preview

DIFFERIN Drug Profile

« Back to Dashboard

Which patents cover Differin, and what generic alternatives are available?

Differin is a drug marketed by Galderma Labs Lp and is included in five NDAs. There are nine patents protecting this drug and one Paragraph IV challenge.

This drug has fifty-five patent family members in twenty-two countries.

The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the adapalene profile page.

Summary for DIFFERIN

International Patents:	55
US Patents:	9
Applicants:	1
NDAs:	5
Suppliers / Packagers:	7
Bulk Api Vendors:	105
Clinical Trials:	19
Patent Applications:	2,269
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for DIFFERIN
Drug Sales Revenues:	Drug sales revenues for DIFFERIN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for DIFFERIN
Prior Art and Litigation Support	Order Prior Art and Litigation support for DIFFERIN
DailyMed Link:	DIFFERIN at DailyMed

Pharmacology for DIFFERIN

Drug Class

Retinoid

Medical Subject Heading (MeSH) Categories for DIFFERIN

Anti-Inflammatory Agents, Non-Steroidal

Dermatologic Agents

Synonyms for DIFFERIN

106685-40-9

1L4806J2QF

2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)-

2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-

4CA-0111

6-(3-((3r,5r,7r)-adamantan-1-yl)-4-methoxyphenyl)-2-naphthoic acid

6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid

6-(3-(Adamantan-1-yl)-4-methoxyphenyl)-2-naphthoic acid

6-(3-adamantan-1-yl-4-methoxyphenyl)naphthalene-2-carboxylic acid

6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid

6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid

6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthalene-carboxylic acid

6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthalenecarboxylic acid

6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid

6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid

6-[3-(adamantan-1-yl)-4-methoxyphenyl]-2-naphthoic acid

6-[3-(adamantan-1-yl)-4-methoxyphenyl]naphthalene-2-carboxylic acid

6-[4-methoxy-3-(tricyclo[3.3.1.1~3,7~]dec-1-yl)phenyl]naphthalene-2-carboxylic acid

6-[4-methoxy-3-(tricyclo[3.3.1.13,7]dec-1-yl)phenyl]naphthalene-2-carboxylic acid

685A409

A2549

A801483

AB0013899

AB01274764_03

AB01274764_04

AB01274764-01

AB01274764-02

AB13763

AB2000023

ABP000590

AC-1974

AC1L1SOH

AC1Q5USH

Adaferin

Adapalen

ADAPALENE

Adapalene (JAN/USAN/INN)

Adapalene [USAN:BAN:INN]

Adapalene [USAN:INN:BAN]

Adapalene for peak identification, European Pharmacopoeia (EP) Reference Standard

Adapalene, >=98% (HPLC)

Adapalene, European Pharmacopoeia (EP) Reference Standard

Adapalene, Pharmaceutical Secondary Standard; Certified Reference Material

Adapalene, United States Pharmacopeia (USP) Reference Standard

Adapalene/

Adapaleno

Adapaleno [INN-Spanish]

Adapalenum

Adapalenum [INN-Latin]

AJ-45604

AK-72900

AKOS005145841

AKOS015895391

AN-593

AOB6389

API0001385

BC205779

BCP02081

BCP9000231

BDBM50048280

BIDD:GT0264

BR-72900

BRD-K33127281-001-01-5

C28H28O3

CAS-106685-40-9

CCG-213060

CCG-221237

CD 271

CD-271

CD271

CHEBI:31174

CHEMBL1265

CHEMBL76401

CPD000466349

CS-1789

CTK8E8906

D01112

DB00210

Differin (TN)

Differin Gel

Differin Gel 0.1%

Differin, Teva, Pimpal, Gallet, Adelene, Adeferin

Differine

DSSTox_CID_26481

DSSTox_GSID_46481

DSSTox_RID_81652

DTXSID5046481

EBD19549

F2173-0588

FT-0631040

GTPL5429

HMS3264F15

HMS3654F11

HMS3715H16

HY-B0091

I06-0642

I810

KB-246947

KS-000002B5

KS-1196

LS-172017

LZCDAPDGXCYOEH-UHFFFAOYSA-N

MFCD03106112

MLS000759463

MLS006010036

MolPort-003-986-211

NAP030

NCGC00164617-01

NCGC00164617-02

NCGC00164617-04

NCGC00164617-05

RTR-001330

S-3513

s1276

SAM001246663

SC-17327

SCHEMBL2747

SMR000466349

SMR002529673

SR-01000942194

SR-01000942194-2

ST2412159

STL453114

SW219282-1

TL8000241

Tox21_112236

Tox21_112236_1

TR-001330

UNII-1L4806J2QF

ZINC3784182

US Patents and Regulatory Information for DIFFERIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Galderma Labs Lp	DIFFERIN	adapalene	CREAM;TOPICAL	020748-001	May 26, 2000	AB	RX	Yes	Yes
Galderma Labs Lp	DIFFERIN	adapalene	GEL;TOPICAL	021753-001	Jun 19, 2007	AB	RX	Yes	Yes			Y
Galderma Labs Lp	DIFFERIN	adapalene	GEL;TOPICAL	021753-001	Jun 19, 2007	AB	RX	Yes	Yes
Galderma Labs Lp	DIFFERIN	adapalene	SOLUTION;TOPICAL	020338-001	May 31, 1996		DISCN	Yes	No

Expired US Patents for DIFFERIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Galderma Labs Lp	DIFFERIN	adapalene	GEL;TOPICAL	021753-001	Jun 19, 2007
Galderma Labs Lp	DIFFERIN	adapalene	CREAM;TOPICAL	020748-001	May 26, 2000
Galderma Labs Lp	DIFFERIN	adapalene	SOLUTION;TOPICAL	020338-001	May 31, 1996
Galderma Labs Lp	DIFFERIN	adapalene	GEL;TOPICAL	021753-001	Jun 19, 2007

Paragraph IV (Patent) Challenges for DIFFERIN

Drugname	Dosage	Strength	RLD	Date
	Topical Gel	0.30%

International Patents for DIFFERIN

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	03075908
Mexico	PA04008684
Austria	432072
Denmark	1532974

Supplementary Protection Certificates for DIFFERIN

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1458369	SPC/GB10/005	United Kingdom		PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
1458369	08C0024	France		PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218